written by reader $2 covid pharma stock

By chuppy1130, June 4, 2020

Kyle Dennis touting a $2 pharma stock, heavy insider buying from CEO, upcoming FDA catalyst and heavily shorted.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.